170 related articles for article (PubMed ID: 35089956)
1. Investigating the effectiveness of adjuvant therapy for patients with hormone receptor-positive ductal carcinoma in situ.
Tsai CJ; Huang HY; Chen FM; Yang YH; Chen LC; Hsieh KP
PLoS One; 2022; 17(1):e0262934. PubMed ID: 35089956
[TBL] [Abstract][Full Text] [Related]
2. Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project.
Thompson AM; Clements K; Cheung S; Pinder SE; Lawrence G; Sawyer E; Kearins O; Ball GR; Tomlinson I; Hanby A; Thomas JSJ; Maxwell AJ; Wallis MG; Dodwell DJ;
Eur J Cancer; 2018 Sep; 101():210-219. PubMed ID: 30092498
[TBL] [Abstract][Full Text] [Related]
3. Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004-2013.
Sagara Y; Freedman RA; Wong SM; Aydogan F; Nguyen A; Barry WT; Golshan M
Breast Cancer Res Treat; 2017 Nov; 166(2):583-592. PubMed ID: 28776282
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery.
Kuo SH; Lo C; Chen YH; Lien HC; Kuo WH; Wang MY; Lee YH; Huang CS
Clin Breast Cancer; 2018 Dec; 18(6):441-450.e2. PubMed ID: 29709458
[TBL] [Abstract][Full Text] [Related]
5. Factors Influencing Use of Hormone Therapy for Ductal Carcinoma In Situ: A National Cancer Database Study.
Nguyen TT; Hoskin TL; Day CN; Habermann EB; Goetz MP; Boughey JC
Ann Surg Oncol; 2017 Oct; 24(10):2989-2998. PubMed ID: 28766214
[TBL] [Abstract][Full Text] [Related]
6. Trade-offs between survival and breast preservation for three initial treatments of ductal carcinoma-in-situ of the breast.
Hillner BE; Desch CE; Carlson RW; Smith TJ; Esserman L; Bear HD
J Clin Oncol; 1996 Jan; 14(1):70-7. PubMed ID: 8558224
[TBL] [Abstract][Full Text] [Related]
7. Patterns of care for ductal carcinoma in situ of the breast: Queensland's experience over a decade.
Barbour S; Moore J; Dunn N; Effeney R; Harden H; McCarthy A; Walpole E; Lehman M
Breast; 2017 Oct; 35():169-176. PubMed ID: 28756338
[TBL] [Abstract][Full Text] [Related]
8. Ten-year results of applying an original scoring system for addressing adjuvant therapy use after breast-conserving surgery for ductal carcinoma in situ of the breast.
Gennaro M; De Santis MC; Mariani L; Lo Vullo S; Cappelletti V; Agresti R; Cortinovis U; Paolini B; Di Cosimo S; Carcangiu ML; Daidone MG; Lozza L
Breast; 2017 Oct; 35():63-68. PubMed ID: 28651115
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary Shared Decision Making in the Management of Ductal Carcinoma In Situ of the Breast.
Parikh P; Pockaj B; Wasif N; Halyard M; Wong W; Kosiorek HE; Dueck AC; Gray R
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(0 3):S516-21. PubMed ID: 25986869
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant radiation therapy alone is associated with improved overall survival compared to hormonal therapy alone in older women with estrogen receptor positive early stage breast cancer.
Jhawar SR; Alpert N; Taioli E; Sayan M; Bazan J; Park KU; Stover D; Cherian M; White J; Haffty B; Ohri N
Cancer Med; 2020 Nov; 9(22):8345-8354. PubMed ID: 32942344
[TBL] [Abstract][Full Text] [Related]
11. Breast conservation among older patients with early-stage breast cancer: Locoregional recurrence following adjuvant radiation or hormonal therapy.
Tringale KR; Berger ER; Sevilimedu V; Wen HY; Gillespie EF; Mueller BA; McCormick B; Xu AJ; Cuaron JJ; Cahlon O; Khan AJ; Powell SN; Morrow M; Heerdt AS; Braunstein LZ
Cancer; 2021 Jun; 127(11):1749-1757. PubMed ID: 33496354
[TBL] [Abstract][Full Text] [Related]
12. Local Relapse After Breast-Conserving Therapy Versus Mastectomy for Extensive Pure Ductal Carcinoma In Situ ≥4 cm.
Hamilton SN; Nichol A; Wai E; Gondara L; Velásquez García HA; Speers C; Diocee R; Truong P
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):381-388. PubMed ID: 30253237
[TBL] [Abstract][Full Text] [Related]
13. Local treatment options for young women with ductal carcinoma in situ: A systematic review and meta-analysis comparing breast conserving surgery with or without adjuvant radiotherapy, and mastectomy.
Chien JC; Liu WS; Huang WT; Shih LC; Liu WC; Chen YC; Chou KJ; Shiue YL; Lin PC
Breast; 2022 Jun; 63():29-36. PubMed ID: 35299032
[TBL] [Abstract][Full Text] [Related]
14. Delay in radiotherapy is associated with an increased risk of disease recurrence in women with ductal carcinoma in situ.
Shurell E; Olcese C; Patil S; McCormick B; Van Zee KJ; Pilewskie ML
Cancer; 2018 Jan; 124(1):46-54. PubMed ID: 28960259
[TBL] [Abstract][Full Text] [Related]
15. Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.
Sagara Y; Freedman RA; Vaz-Luis I; Mallory MA; Wong SM; Aydogan F; DeSantis S; Barry WT; Golshan M
J Clin Oncol; 2016 Apr; 34(11):1190-6. PubMed ID: 26834064
[TBL] [Abstract][Full Text] [Related]
16. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
17. Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 cases.
Corradini S; Pazos M; Schönecker S; Reitz D; Niyazi M; Ganswindt U; Schrodi S; Braun M; Pölcher M; Mahner S; Harbeck N; Engel J; Belka C
Radiat Oncol; 2018 Feb; 13(1):25. PubMed ID: 29426355
[TBL] [Abstract][Full Text] [Related]
18. The Selection of Treatment Modality for Breast Ductal Carcinoma In Situ: Experience From a Single Institution.
You KY; Bi ZF; Ma YJ; Mao YL; Zou WL; Liu YM; Yao HR
Cancer Control; 2021; 28():1073274821997426. PubMed ID: 33626920
[TBL] [Abstract][Full Text] [Related]
19. The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive Breast cancer (iIBC) in the Dutch population.
Alaeikhanehshir S; Schmitz RSJM; van den Belt-Dusebout AW; van Duijnhoven FH; Verschuur E; van Seijen M; Schaapveld M; Lips EH; Wesseling J;
Breast Cancer Res Treat; 2024 Feb; 204(1):61-68. PubMed ID: 37964135
[TBL] [Abstract][Full Text] [Related]
20. Patterns of care analysis among women with ductal carcinoma in situ in North Carolina.
Jackson LC; Camacho F; Levine EA; Anderson RT; Stewart JH
Am J Surg; 2008 Feb; 195(2):164-9. PubMed ID: 18096124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]